These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25446731)

  • 1. IBD pathogenesis in 2014: Molecular pathways controlling barrier function in IBD.
    Atreya R; Neurath MF
    Nat Rev Gastroenterol Hepatol; 2015 Feb; 12(2):67-8. PubMed ID: 25446731
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
    Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
    Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.
    Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M
    Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR activation inhibits inflammation and preserves the intestinal barrier in IBD.
    Wildenberg ME; van den Brink GR
    Gut; 2011 Apr; 60(4):432-3. PubMed ID: 21270116
    [No Abstract]   [Full Text] [Related]  

  • 6. Mediators of inflammation: production and implication in inflammatory bowel disease.
    Kolios G; Petoumenos C; Nakos A
    Hepatogastroenterology; 1998; 45(23):1601-9. PubMed ID: 9840114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.
    Henderson P; van Limbergen JE; Schwarze J; Wilson DC
    Inflamm Bowel Dis; 2011 Jan; 17(1):382-95. PubMed ID: 20645321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: Pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilarities in clinical findings.
    Orchard T; Jewell DP
    Aliment Pharmacol Ther; 1997 Dec; 11 Suppl 3():10-5; discussion 15-6. PubMed ID: 9467974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediators of mucosal inflammation: implications for therapy.
    van Dullemen H; Meenan J; Stronkhorst A; Tytgat GN; van Deventer SJ
    Scand J Gastroenterol Suppl; 1997; 223():92-8. PubMed ID: 9200313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dual role for prostaglandin D2 in intestinal epithelial homeostasis].
    Le Loupp AG; Bach-Ngohou K; Bettan A; Denis M; Masson D
    Med Sci (Paris); 2015; 31(6-7):617-21. PubMed ID: 26152165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues.
    Valatas V; Bamias G; Kolios G
    Eur J Pharmacol; 2015 Jul; 759():253-64. PubMed ID: 25814256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CDX2 in inflammatory bowel disease.
    Coskun M
    Dan Med J; 2014 Mar; 61(3):B4820. PubMed ID: 24814920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinician's guide through the tight junctions [editoria; comment].
    Hollander D
    Ital J Gastroenterol Hepatol; 1999; 31(6):435-9. PubMed ID: 10575558
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution of autophagy to intestinal homeostasis and pathology].
    Trentesaux C; Fraudeau M; Romagnolo B
    Med Sci (Paris); 2017 Mar; 33(3):290-296. PubMed ID: 28367816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of GRß in colonic mucosal cell line partly reflects altered gene expression in colonic mucosa of patients with inflammatory bowel disease.
    Nagy Z; Acs B; Butz H; Feldman K; Marta A; Szabo PM; Baghy K; Pazmany T; Racz K; Liko I; Patocs A
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):76-84. PubMed ID: 26480216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.
    Goyette P; Labbé C; Trinh TT; Xavier RJ; Rioux JD
    Ann Med; 2007; 39(3):177-99. PubMed ID: 17457716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokines in chronic intestinal inflammation].
    Reinecker C; Steffen M; Witthöft T; Schreiber S; Raedler A
    Verh Dtsch Ges Inn Med; 1991; 97():477-81. PubMed ID: 1808931
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteases and small intestinal barrier function in health and disease.
    Giuffrida P; Biancheri P; MacDonald TT
    Curr Opin Gastroenterol; 2014 Mar; 30(2):147-53. PubMed ID: 24445329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-α-induced intestinal epithelial cell shedding: implications for intestinal barrier function.
    Watson AJ; Hughes KR
    Ann N Y Acad Sci; 2012 Jul; 1258():1-8. PubMed ID: 22731709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.